These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25435189)

  • 1. Epithelial-mesenchymal transition‑associated microRNAs in colorectal cancer and drug-targeted therapies (Review).
    Jin D; Fang Y; Li Z; Chen Z; Xiang J
    Oncol Rep; 2015 Feb; 33(2):515-25. PubMed ID: 25435189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
    Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
    Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial mesenchymal transition in colorectal cancer: Seminal role in promoting disease progression and resistance to neoadjuvant therapy.
    Bhangu A; Wood G; Mirnezami A; Darzi A; Tekkis P; Goldin R
    Surg Oncol; 2012 Dec; 21(4):316-23. PubMed ID: 22981546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs in colorectal cancer metastasis.
    de Krijger I; Mekenkamp LJ; Punt CJ; Nagtegaal ID
    J Pathol; 2011 Aug; 224(4):438-47. PubMed ID: 21706478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of peroxiredoxin 2 inhibits TGF-β1-induced epithelial-mesenchymal transition and cell migration in colorectal cancer.
    Feng J; Fu Z; Guo J; Lu W; Wen K; Chen W; Wang H; Wei J; Zhang S
    Mol Med Rep; 2014 Aug; 10(2):867-73. PubMed ID: 24920174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs in colorectal carcinoma--from pathogenesis to therapy.
    Chi Y; Zhou D
    J Exp Clin Cancer Res; 2016 Mar; 35():43. PubMed ID: 26964533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-to-mesenchymal transition and cancer stem(-like) cells in head and neck squamous cell carcinoma.
    Chen C; Zimmermann M; Tinhofer I; Kaufmann AM; Albers AE
    Cancer Lett; 2013 Sep; 338(1):47-56. PubMed ID: 22771535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
    Xia H; Hui KM
    Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs: promising biomarkers for diagnosis and therapeutic targets in human colorectal cancer metastasis.
    Hur K
    BMB Rep; 2015 Apr; 48(4):217-22. PubMed ID: 25603797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs in Epithelial-Mesenchymal Transition Process of Cancer: Potential Targets for Chemotherapy.
    Peng F; Fan H; Li S; Peng C; Pan X
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial-mesenchymal transition (EMT): principles and clinical impact in cancer therapy.
    Franco-Chuaire ML; Magda Carolina SC; Chuaire-Noack L
    Invest Clin; 2013 Jun; 54(2):186-205. PubMed ID: 23947008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines.
    Yang AD; Fan F; Camp ER; van Buren G; Liu W; Somcio R; Gray MJ; Cheng H; Hoff PM; Ellis LM
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4147-53. PubMed ID: 16857785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs as Therapeutic Targets and Colorectal Cancer Therapeutics.
    Yamamoto H; Mori M
    Adv Exp Med Biol; 2016; 937():239-47. PubMed ID: 27573904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel therapeutic strategies: targeting epithelial-mesenchymal transition in colorectal cancer.
    Zhang N; Ng AS; Cai S; Li Q; Yang L; Kerr D
    Lancet Oncol; 2021 Aug; 22(8):e358-e368. PubMed ID: 34339656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New role of microRNA: carcinogenesis and clinical application in cancer.
    Zhao L; Chen X; Cao Y
    Acta Biochim Biophys Sin (Shanghai); 2011 Nov; 43(11):831-9. PubMed ID: 21908856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs as potential drug targets for therapeutic intervention in colorectal cancer.
    Jafri MA; Zaidi SK; Ansari SA; Al-Qahtani MH; Shay JW
    Expert Opin Ther Targets; 2015; 19(12):1705-23. PubMed ID: 26189482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact.
    Foroni C; Broggini M; Generali D; Damia G
    Cancer Treat Rev; 2012 Oct; 38(6):689-97. PubMed ID: 22118888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review of the old and new concepts in the epithelial-mesenchymal transition of colorectal cancer.
    Gurzu S; Silveanu C; Fetyko A; Butiurca V; Kovacs Z; Jung I
    World J Gastroenterol; 2016 Aug; 22(30):6764-75. PubMed ID: 27570416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.
    Liu H; Ren G; Wang T; Chen Y; Gong C; Bai Y; Wang B; Qi H; Shen J; Zhu L; Qian C; Lai M; Shao J
    Carcinogenesis; 2015 Apr; 36(4):459-68. PubMed ID: 25750173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of DACH1 promotes migration and invasion of colorectal cancer via activating TGF-β-mediated epithelial-mesenchymal transition.
    Wang P
    Biochem Biophys Res Commun; 2015 May; 460(2):314-9. PubMed ID: 25778865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.